APRE Earnings

Quarterly EPS
$-0.64
Q3 2024
$-0.49
Q4 2024
$-0.66
Q1 2025
$-0.53
Q2 2025
$-0.47
Q3 2025
$-0.32
Q4 2025
$-0.22
Q1 2026
$-0.07
Q2 2026
Latest RevenueN/A
Latest Net Income-3591304
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.070-3591304-100.0%+86.8%
Q1 2026-$0.220-3287917-100.0%+66.7%
Q4 2025-$0.323.3K-2455630-98.4%+34.7%
Q3 2025-$0.471.8K-2972410-99.5%+26.6%
Q2 2025-$0.53118.1K-3238870-79.0%+8.6%
Q1 2025-$0.66162.5K-3932659-57.3%+1.5%
Q4 2024-$0.49205.8K-2894799+1,362.3%+46.7%
Q3 2024-$0.64354.6K-3783769+11.0%+25.6%
Q2 2024-$0.58561.6K-3470052
Q1 2024-$0.67380.6K-2810091
Q4 2023-$0.9214.1K-3443254
Q3 2023-$0.86319.5K-3204515
Aprea Therapeutics (APRE) — Earnings